Coupled plasma filtration adsorption in patients with a history of kidney transplantation: Report of two cases

Quirino Lai, Verdiana Di Pietro, Samuele Iesari, Sofia Amabili, Linda De Luca, Katia Clemente, Antonio Famulari, Francesco Pisani

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Coupled plasma filtration adsorption (CPFA) is an extracorporeal treatment based on plasma filtration associated with an adsorbent cartridge and hemofiltration. CPFA is able to remove inflammatory mediators and it has been used to treat severe sepsis, septic shock and multiple organ dysfunction syndrome. Limited experience exists on the use of CPFA after solid organ transplantation. We report our experience with CPFA in 2 kidney transplant recipients with post-nephrolithotomy septic shock and severe unexplained rhabdomyolysis. In both the cases, excellent results were observed. In selected cases, CPFA can be safely and effectively used in patients with a solid organ transplant. However, additional studies are needed in this particular setting, to further investigate the potential role of CPFA for the treatment of other conditions associated with excessive inflammation, such as in rheumatologic disorders and delayed graft function.

Original languageEnglish
Pages (from-to)218-222
Number of pages5
JournalBlood Purification
Volume40
Issue number3
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Kidney Transplantation
Adsorption
Septic Shock
Delayed Graft Function
Hemofiltration
Rhabdomyolysis
Multiple Organ Failure
Organ Transplantation
Sepsis
Inflammation
Transplants
Kidney
Therapeutics

Keywords

  • Cytokines
  • Graft survival
  • Myoglobin
  • Rhabdomyolysis
  • Sepsis

ASJC Scopus subject areas

  • Nephrology
  • Hematology

Cite this

Coupled plasma filtration adsorption in patients with a history of kidney transplantation : Report of two cases. / Lai, Quirino; Di Pietro, Verdiana; Iesari, Samuele; Amabili, Sofia; De Luca, Linda; Clemente, Katia; Famulari, Antonio; Pisani, Francesco.

In: Blood Purification, Vol. 40, No. 3, 01.10.2015, p. 218-222.

Research output: Contribution to journalArticle

Lai, Q, Di Pietro, V, Iesari, S, Amabili, S, De Luca, L, Clemente, K, Famulari, A & Pisani, F 2015, 'Coupled plasma filtration adsorption in patients with a history of kidney transplantation: Report of two cases', Blood Purification, vol. 40, no. 3, pp. 218-222. https://doi.org/10.1159/000437042
Lai, Quirino ; Di Pietro, Verdiana ; Iesari, Samuele ; Amabili, Sofia ; De Luca, Linda ; Clemente, Katia ; Famulari, Antonio ; Pisani, Francesco. / Coupled plasma filtration adsorption in patients with a history of kidney transplantation : Report of two cases. In: Blood Purification. 2015 ; Vol. 40, No. 3. pp. 218-222.
@article{ae58fc48802e488cb490d2ab5df47478,
title = "Coupled plasma filtration adsorption in patients with a history of kidney transplantation: Report of two cases",
abstract = "Coupled plasma filtration adsorption (CPFA) is an extracorporeal treatment based on plasma filtration associated with an adsorbent cartridge and hemofiltration. CPFA is able to remove inflammatory mediators and it has been used to treat severe sepsis, septic shock and multiple organ dysfunction syndrome. Limited experience exists on the use of CPFA after solid organ transplantation. We report our experience with CPFA in 2 kidney transplant recipients with post-nephrolithotomy septic shock and severe unexplained rhabdomyolysis. In both the cases, excellent results were observed. In selected cases, CPFA can be safely and effectively used in patients with a solid organ transplant. However, additional studies are needed in this particular setting, to further investigate the potential role of CPFA for the treatment of other conditions associated with excessive inflammation, such as in rheumatologic disorders and delayed graft function.",
keywords = "Cytokines, Graft survival, Myoglobin, Rhabdomyolysis, Sepsis",
author = "Quirino Lai and {Di Pietro}, Verdiana and Samuele Iesari and Sofia Amabili and {De Luca}, Linda and Katia Clemente and Antonio Famulari and Francesco Pisani",
year = "2015",
month = "10",
day = "1",
doi = "10.1159/000437042",
language = "English",
volume = "40",
pages = "218--222",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Coupled plasma filtration adsorption in patients with a history of kidney transplantation

T2 - Report of two cases

AU - Lai, Quirino

AU - Di Pietro, Verdiana

AU - Iesari, Samuele

AU - Amabili, Sofia

AU - De Luca, Linda

AU - Clemente, Katia

AU - Famulari, Antonio

AU - Pisani, Francesco

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Coupled plasma filtration adsorption (CPFA) is an extracorporeal treatment based on plasma filtration associated with an adsorbent cartridge and hemofiltration. CPFA is able to remove inflammatory mediators and it has been used to treat severe sepsis, septic shock and multiple organ dysfunction syndrome. Limited experience exists on the use of CPFA after solid organ transplantation. We report our experience with CPFA in 2 kidney transplant recipients with post-nephrolithotomy septic shock and severe unexplained rhabdomyolysis. In both the cases, excellent results were observed. In selected cases, CPFA can be safely and effectively used in patients with a solid organ transplant. However, additional studies are needed in this particular setting, to further investigate the potential role of CPFA for the treatment of other conditions associated with excessive inflammation, such as in rheumatologic disorders and delayed graft function.

AB - Coupled plasma filtration adsorption (CPFA) is an extracorporeal treatment based on plasma filtration associated with an adsorbent cartridge and hemofiltration. CPFA is able to remove inflammatory mediators and it has been used to treat severe sepsis, septic shock and multiple organ dysfunction syndrome. Limited experience exists on the use of CPFA after solid organ transplantation. We report our experience with CPFA in 2 kidney transplant recipients with post-nephrolithotomy septic shock and severe unexplained rhabdomyolysis. In both the cases, excellent results were observed. In selected cases, CPFA can be safely and effectively used in patients with a solid organ transplant. However, additional studies are needed in this particular setting, to further investigate the potential role of CPFA for the treatment of other conditions associated with excessive inflammation, such as in rheumatologic disorders and delayed graft function.

KW - Cytokines

KW - Graft survival

KW - Myoglobin

KW - Rhabdomyolysis

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=84941254506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941254506&partnerID=8YFLogxK

U2 - 10.1159/000437042

DO - 10.1159/000437042

M3 - Article

C2 - 26329728

AN - SCOPUS:84941254506

VL - 40

SP - 218

EP - 222

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 3

ER -